home > ebr > > minimising volume, maximising returns


Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time. Sign up now!

       Already registered? Please sign in.

Alternatively, please use our pay-per-view service.


Industry Events

Genome Editing Applications

2-3 December 2015, Sheraton Brussels Airport Hotel, Brussels, Belgium

Informa Life Sciences’are proud to announce the launch of our inaugural Genome Editing Applications conference, showcasing the most up-to-date therapeutic and biomedical applications of genome editing technologies.
More info >>

News and Press Releases

Goodwin Biotechnology Announces the Completion of cGMP Manufacturing of an IgM Monoclonal Antibody and IgM-Ligand Conjugate for Q Therapeutics, and Successful Clearance of Q Therapeutics’ IND Submission for Q‐Cells® Cell Therapy in ALS

Goodwin Biotechnology, Inc., a biological Contract Development and Manufacturing Organization (CDMO) that specializes in bioprocess development and GMP manufacturing of biopharmaceuticals utilizing Mammalian Cell Culture expression systems and Bioconjugation technologies, has partnered with Q Therapeutics, Inc., a clinical‐stage developer of novel cellular therapies for central nervous system (CNS) diseases to provide GMP antibodies for manufacture of clinical trial materials.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement